Compare
Balchem Corp vs Ingevity Corp vs Ecovyst Inc. vs Innospec Inc.
| Latest fiscal year | Balchem Corp BCPC | Ingevity Corp NGVT | Ecovyst Inc. ECVT | Innospec Inc. IOSP |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.04B | $1.17B | $723.51M | $1.78B |
| Revenue growth (YoY) | +8.8% | -2.7% | +20.9% | -3.7% |
| Gross margin | 35.7% | 39.5% | 21.8% | 27.7% |
| Operating margin | 20.2% | 35.9% | 9.0% | 7.3% |
| Net margin | 14.9% | -14.3% | -9.8% | 6.6% |
| Net income | $154.84M | -$167.10M | -$71.13M | $116.60M |
| EPS (Diluted) | $4.75 | -$4.61 | -$0.61 | $4.67 |
| Operating cash flow | $216.56M | $331.20M | $140.31M | $138.30M |
| Free cash flow | n/a | $273.50M | $69.89M | n/a |
| Cash & equivalents | $74.57M | $78.10M | $197.19M | $292.50M |
| Total assets | $1.69B | $1.65B | $1.26B | $1.83B |
| Total liabilities | $428.84M | $1.62B | $657.54M | $499.50M |
| Shareholders' equity | $1.26B | $29.70M | $603.44M | $1.33B |
| Return on year-end equity | 12.3% | -562.6% | -11.8% | 8.8% |
| Shares outstanding | 32.06M | 35.49M | 111.81M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Balchem Corp | Ingevity Corp | Ecovyst Inc. | Innospec Inc. |
|---|---|---|---|---|
| Latest | $1.04B Ended 2025-12-31 | $1.17B Ended 2025-12-31 | $723.51M Ended 2025-12-31 | $1.78B Ended 2025-12-31 |
| 1 year earlier | $953.68M Ended 2024-12-31 | $1.20B Ended 2024-12-31 | $598.29M Ended 2024-12-31 | $1.85B Ended 2024-12-31 |
| 2 years earlier | $922.44M Ended 2023-12-31 | $1.22B Ended 2023-12-31 | $584.85M Ended 2023-12-31 | $1.95B Ended 2023-12-31 |
| 3 years earlier | $942.36M Ended 2022-12-31 | $1.67B Ended 2022-12-31 | $820.16M Ended 2022-12-31 | $1.96B Ended 2022-12-31 |
| 4 years earlier | $799.02M Ended 2021-12-31 | $1.39B Ended 2021-12-31 | $611.20M Ended 2021-12-31 | $1.48B Ended 2021-12-31 |